Akamai files Form 144 to sell 17,000 shares

Akamai Technologies filed a Form 144 proposing the sale of 17,000 common shares tied to RSU/PSU awards, dated 02/19/2026.

Accepted by SEC EDGAR 03/12/2026 - 04:11 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Akamai Technologies filed a Form 144 proposing the sale of 17,000 common shares tied to RSU/PSU awards, dated 02/19/2026. The notice lists prior dispositions by Adam Karon of 3,320 shares on 01/02/2026 and 4,728 shares on 03/02/2026 with gross proceeds of 289,836.00 and 458,190.00 respectively. Shares outstanding are shown as 144,888,114 as of 03/12/2026.

Insights

Securities Compliance Counsel

Form 144 notifies resale of 17,000 RSU/PSU‑related shares; prior small dispositions reported.

The filing lists a proposed sale of 17,000 common shares associated with equity compensation dated 02/19/2026. It records two recent dispositions by an affiliate, including 3,320 shares on 01/02/2026 and 4,728 shares on 03/02/2026, with gross proceeds shown as 289,836.00 and 458,190.00.

These entries are procedural notices under resale rules; cash‑flow treatment and distribution method are not specified in the excerpt. Subsequent filing updates or broker settlement records would clarify execution details and whether sales were block trades, brokerage transactions, or other permitted methods.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Akamai's Form 144 for 17,000 shares mean (AKAM)?

It notifies a proposed resale of 17,000 common shares tied to RSU/PSU awards dated 02/19/2026. The filing is a regulatory notice and does not itself confirm sale execution or proceeds.

Who reported recent share sales in the Akamai filing (AKAM)?

The excerpt lists transactions by Adam Karon: 3,320 shares on 01/02/2026 and 4,728 shares on 03/02/2026, with gross proceeds of 289,836.00 and 458,190.00 respectively.

How many shares outstanding does Akamai show in this excerpt (AKAM)?

The filing shows 144,888,114 shares outstanding as of 03/12/2026. This figure is presented as a baseline in the excerpt and is distinct from the proposed resale amount.

Does the Form 144 confirm how the 17,000 shares will be sold (AKAM)?

The excerpt indicates the securities are RSU/PSU‑related but does not specify the distribution method. Details on block trades, brokerage transactions, or timing are not provided in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001699796
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AKAMAI TECHNOLOGIES INC
SEC File Number	000-27275
Address of Issuer	145 BROADWAY CAMBRIDGE MASSACHUSETTS 02142
Phone	6174443000
Name of Person for Whose Account the Securities are To Be Sold	Karon Adam
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	17000	1826249.00	144888114	03/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/19/2026	RSU / PSU - See Remarks	AKAMAI TECHNOLOGIES INC			17000	02/19/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adam Karon 145 BROADWAY CAMBRIDGE MA 02142	AKAMAI TECHNOLOGIES INC	01/02/2026	3320	289836.00
Adam Karon 145 BROADWAY CAMBRIDGE MA 02142	AKAMAI TECHNOLOGIES INC	03/02/2026	4728	458190.00

144: Remarks and Signature

Remarks	The shares sold in this filing were acquired and paid for between 2/19/2026 and 3/06/2026.
Date of Notice	03/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Adam Karon
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)